What's Happening?
Researchers from Charité - Universitätsmedizin Berlin have developed a new non-surgical treatment for knee osteoarthritis, which has shown promising results in a 12-month trial. The procedure, known as genicular artery embolization (GAE), targets abnormal
blood vessels and pain-sensing nerves associated with osteoarthritis. By blocking these blood vessels, the treatment reduces inflammation and pain. The study involved 194 participants with a mean age of 69, who had not responded to other treatments. Over the course of the study, participants reported a significant reduction in pain intensity from an average of 7 to 3 out of 10, along with improvements in daily activities and quality of life. The treatment did not result in any notable side effects.
Why It's Important?
This development is significant as it offers a new treatment option for patients with knee osteoarthritis who are not candidates for surgery or have not found relief from other treatments. Osteoarthritis is a common and debilitating condition affecting millions worldwide, and current treatment options are limited. The success of this minimally invasive procedure could provide a much-needed alternative for pain management and improve the quality of life for many patients. Additionally, the use of resorbable microspheres in the procedure addresses concerns about inflammation and antibiotic resistance associated with previous methods.
What's Next?
Future research will focus on larger and longer-term studies to further validate the effectiveness of this treatment. A fully randomized clinical trial is needed to compare its efficacy against other treatments or placebos. If successful, this procedure could become a standard treatment option for knee osteoarthritis, potentially reducing the need for more invasive surgeries like knee replacements.
